TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · major macro event coming up
IQV

IQVIA Holdings Inc

Healthcare · Diagnostics & Research

270.10$ +0.1% vs. previous close Closing price · As of: Sep 22, 2026

Statements

Cash Flow

All figures as a percentage of revenue in the same period.

Tick rows to compare them in a chart (up to 4)

Cash Flow IQV
Line item 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
7.9% 8.3% 12.6% 10.0% 12.0% 12.8% 17.2% 21.2% 15.7% 14.3% 17.6% 16.3%
2.2% 2.2% 4.2% 10.4% 11.0% 10.8% 11.3% 9.1% 7.8% 7.5% 7.2% 7.0%
0.5% 0.7% 1.2% 1.1% 1.1% 1.3% 0.8% 1.2% 1.3% 1.4% 1.3% 1.5%
-0.1% 0.2% 2.9% -11.2% -0.7% -0.4% -1.0% 0.1% 0.7%
-0.8% -1.2% 3.1% -3.0% -1.0% 0.2% 4.0% 4.9% -0.6% -1.9% 1.0% 0.8%
1.5% 1.4% 2.4% 3.8% 4.4% 5.2% 5.4% 4.6% 4.7% 4.3% 3.9% 3.7%
-3.2% -1.2% 25.4% -12.3% -7.8% -10.7% -7.0% -15.2% -13.9% -10.7% -9.4% -14.1%
7.8% 39.2% 9.4% 73.8% 39.1% 0.1% 0.4% 0.4%
-7.6% -9.0% -16.1% -27.0% -13.5% -8.6% -3.9% -2.9% -8.1% -6.6% -8.8% -7.6%
4.4% 2.9% -21.9% 25.4% 9.5% 6.3% 2.7% 0.5% 6.5% 5.4% 3.6% 7.6%
-2.4% -4.3% -33.5% -0.7% -4.3% -2.5% -1.9% -8.9% -2.3% -2.5% -5.7% -0.9%
1.6% 1.9% 3.2% -2.5% -0.7% -0.5% 8.6% -3.2% -1.0% 1.1% 2.1% 1.7%
6.4% 6.9% 10.2% 6.2% 7.6% 7.5% 11.8% 16.6% 11.0% 10.0% 13.7% 12.6%

Data as of: September 22, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?